| scholarly article | Q13442814 |
| P50 | author | Line De Kimpe | Q39200751 |
| P2093 | author name string | Helma Rutjes | |
| Wiep Scheper | |||
| Elise S van Haastert | |||
| Jeroen J M Hoozemans | |||
| Rob Zwart | |||
| Archontia Kaminari | |||
| P2860 | cites work | ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models | Q24628845 |
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations | Q28506710 | ||
| Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis | Q29547501 | ||
| Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions | Q30320504 | ||
| Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model | Q30489966 | ||
| Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis | Q30497751 | ||
| Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease | Q31853538 | ||
| Binding and uptake of A beta1-42 by primary human astrocytes in vitro | Q33390631 | ||
| Accumulation of intraneuronal Abeta correlates with ApoE4 genotype | Q33771171 | ||
| Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits | Q34438646 | ||
| Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion | Q36370419 | ||
| Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease | Q36611961 | ||
| Autophagy, amyloidogenesis and Alzheimer disease | Q37011121 | ||
| Inflammaging as a prodrome to Alzheimer's disease | Q37041389 | ||
| Neurodegenerative lysosomal disorders: a continuum from development to late age. | Q37170688 | ||
| From alpha to omega with Abeta: targeting the multiple molecular appearances of the pathogenic peptide in Alzheimer's disease. | Q37705466 | ||
| Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. | Q39746539 | ||
| Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake | Q39965077 | ||
| Abeta 1-42 induces mild endoplasmic reticulum stress in an aggregation state-dependent manner. | Q40057785 | ||
| Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. | Q40677042 | ||
| Endoplasmic reticulum stress activates autophagy but not the proteasome in neuronal cells: implications for Alzheimer's disease | Q41870879 | ||
| Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins | Q43026196 | ||
| Protein degradation during aging: the lysosome-, the calpain- and the proteasome-dependent cellular proteolytic systems | Q43996363 | ||
| Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival | Q44158602 | ||
| Rab6 membrane association is dependent of Presenilin 1 and cellular phosphorylation events | Q44781784 | ||
| Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology | Q46330873 | ||
| Brain aging and Aβ1–42 neurotoxicity converge via deterioration in autophagy–lysosomal system: a conditional Drosophila model linking Alzheimer’s neurodegeneration with aging | Q47600265 | ||
| Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease | Q47962016 | ||
| Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice | Q48846848 | ||
| Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain | Q48917681 | ||
| Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease | Q49097822 | ||
| Phagocytic activity of human adult astrocytes and oligodendrocytes in culture | Q69531270 | ||
| The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain | Q74290658 | ||
| On the seeding and oligomerization of pGlu-amyloid peptides (in vitro) | Q79212522 | ||
| N-truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis | Q80217620 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 673-687 | |
| P577 | publication date | 2012-04-04 | |
| P1433 | published in | Age | Q4691832 |
| P1476 | title | Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Aβ pathology at the lysosome | |
| P478 | volume | 35 |
| Q59790774 | A pH probe inhibits senescence in mesenchymal stem cells |
| Q46320596 | APP/Aβ structural diversity and Alzheimer's disease pathogenesis |
| Q27301082 | Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons |
| Q36744769 | Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons |
| Q46335422 | Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition |
| Q51819730 | Detection and Quantification of β-Amyloid, Pyroglutamyl Aβ, and Tau in Aged Canines. |
| Q34412693 | Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer's disease in vitro |
| Q36869450 | Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification. |
| Q92529636 | Endolysosome and Autolysosome Dysfunction in Alzheimer's Disease: Where Intracellular and Extracellular Meet |
| Q102053823 | Extracellular vesicles from amyloid-β exposed cell cultures induce severe dysfunction in cortical neurons |
| Q28555118 | Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity |
| Q91861038 | Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease |
| Q35679473 | Mitochondrial dysfunction induced by a post-translationally modified amyloid linked to a familial mutation in an alternative model of neurodegeneration |
| Q55398317 | Modeling Protein Aggregation and the Heat Shock Response in ALS iPSC-Derived Motor Neurons. |
| Q38873518 | One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina. |
| Q36396174 | Oxidative stress and mitochondria-mediated cell death mechanisms triggered by the familial Danish dementia ADan amyloid |
| Q28550062 | Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy |
| Q38176899 | Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy |
| Q93089168 | Spontaneous Isomerization of Long-Lived Proteins Provides a Molecular Mechanism for the Lysosomal Failure Observed in Alzheimer's Disease |
| Q64897399 | TFEB Probably Involved in Midazolam-Disturbed Lysosomal Homeostasis and Its Induced β-Amyloid Accumulation. |
| Q89052844 | Unveiling Brain Aβ Heterogeneity Through Targeted Proteomic Analysis |
Search more.